CYTIVA
LIVE

Serial Number

88983829

Owner

Life Sciences IP Holdings Corporation

Attorney

Dyan House

First Use Date

Apr 1, 2020

Filing Date

May 1, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CYTIVA Trademark

Serial Number: 88983829 • Registration: 6694944

CYTIVA is a trademark filed by Life Sciences IP Holdings Corporation on May 1, 2020. The trademark is classified under Class 40 (Treatment & Processing), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Life Sciences IP Holdings Corporation (40 trademarks)

Washington, DC 20037

Entity Type: 03

Trademark Details

Filing Date

May 1, 2020

Registration Date

April 5, 2022

First Use Anywhere

April 1, 2020

First Use in Commerce

April 1, 2020

Published for Opposition

February 9, 2021

Goods & Services

Customer training and educational courses in the fields of chemicals, life science, pharmaceuticals, biotherapeutics, cell and gene therapy production; education services, namely, conducting classes, seminars, and virtual workshops in the field of automation of biomanufacturing processes; training relating to the automation of biomanufacturing processes; education services, namely, conducting classes, seminars, and virtual workshops in the field of biomanufacturing; education services, namely, conducting classes, seminars, and virtual workshops relating to biomanufacturing, bioprocessing, cell and gene therapy, and production-scale manufacturing of biopharmaceuticals, engineering; education services, namely, providing training courses, seminars and instructional classes in the field(s) of life sciences and bioprocessing; training and educational courses in relation to scientific apparatus, scientific instruments, and life science software; training relating to the use, calibration, re-calibration and servicing of scientific apparatus and instruments; education services related to cell and gene therapy implemented with cryochain technology, biomanufacturing and bioprocessing, and production-scale manufacturing of biopharmaceuticals, in the form of classes, seminars, and courses of instruction

Research, advising, and consulting related to life sciences, laboratory support services being medical and scientific laboratory services, laboratory testing, laboratory analysis, development of pharmaceutical products, environmental testing, virology, bacteriology, bioprocess science, medical and scientific research concerning cell and gene therapy, development of vaccine products, food and beverage testing; software as a service, namely, software for analyzing and processing large sets of data; scientific research and consulting in the field of building construction and construction of customized, pre-fabricated, and deliverable research and production facilities; product research and development in life sciences and bioprocessing; development of cloud based computer programs for simulating laboratory testing; providing on-line non-downloadable computer modeling software for biopharma process development; software as a service (SAAS) services, platform as a service (PAAS), and cloud based services featuring software for customization, optimization, utilization, modeling, and emulation relating to bioprocessing and bioprocess development; software as a service (SAAS) services featuring manufacturing execution system (MES) software for the pharmaceutical and biotechnology industries; design of bioprocessing facility buildings and rooms therein for the life sciences industry; bioprocess engineering; process development services; scientific consultancy and advising in the fields of bioprocess production methods and production lines; design and development of bioprocess products and production line products; providing an online portal featuring information in the life sciences field; providing temporary use of non-downloadable software, namely, software for optimization, obtaining performance data, maintenance, remote diagnostics and troubleshooting, connectivity, calibration qualification, processing trade-ins, and providing information about spare parts and kits, all for life science and bioprocess equipment ; technical support services, namely, troubleshooting of computer hardware and software problems; testing, analysis and evaluation of the goods of others to determine conformity with certification standards; rental and donation of laboratory apparatus and instruments; platform as a service (PAAS) services featuring educational computer software platforms for providing online learning and virtual classrooms in the fields of life sciences, laboratory support, laboratory testing, laboratory analysis, pharmaceutical production, environmental testing, virology, bacteriology, bioprocess, cell and gene therapy, vaccine production, food and beverage testing; designing biomanufacturing process lines for the life sciences industry; shared information technology infrastructure services for the production of biopharmaceuticals

Consulting in the field of contract manufacturing in life sciences and bioprocessing

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 5, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 5, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 5, 2025 REAP
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Jan 17, 2023 NURC
CORRECTION UNDER SECTION 7 - PROCESSED
Dec 13, 2022 COC.
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Dec 7, 2022 EROP
POST REGISTRATION ACTION MAILED - SEC. 7
Dec 6, 2022 PRAM
POST REGISTRATION ACTION CORRECTION
Dec 6, 2022 XXXX
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 6, 2022 APRE
OTQR WITHDRAWAL FROM PUBLICATION
Nov 30, 2022 WDRL
CORRECTION UNDER SECTION 7 - PROCESSED
Oct 18, 2022 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 12, 2022 APRE
TEAS SECTION 7 REQUEST RECEIVED
May 16, 2022 ES7R
REGISTERED-PRINCIPAL REGISTER
Apr 5, 2022 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 4, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 3, 2022 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Feb 16, 2022 SUPC
DIVISIONAL PROCESSING COMPLETE
Feb 16, 2022 DPCC
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 2, 2022 TROA
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Feb 2, 2022 INCD
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 2, 2022 AITU
DIVISIONAL REQUEST RECEIVED
Jan 31, 2022 DRRR
USE AMENDMENT FILED
Jan 21, 2022 IUAF
TEAS REQUEST TO DIVIDE RECEIVED
Jan 21, 2022 ERTD
TEAS STATEMENT OF USE RECEIVED
Jan 21, 2022 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 6, 2021 EXRA
SOU EXTENSION 1 GRANTED
Oct 4, 2021 EX1G
SOU EXTENSION 1 FILED
Oct 4, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 4, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 6, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 9, 2021 NPUB
PUBLISHED FOR OPPOSITION
Feb 9, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 20, 2021 NONP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 5, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 5, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 5, 2021 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 4, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 4, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 4, 2021 COAR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 4, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 26, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 25, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 25, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 28, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jul 28, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jul 28, 2020 CNRT
ASSIGNED TO EXAMINER
Jul 27, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 14, 2020 NWOS
NEW APPLICATION ENTERED
May 5, 2020 NWAP